Baker, Julia M <br/><br/>
Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.  [electronic resource] 

 -  PLoS medicine  12 2019 
 - e1003005 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-1676 
<br/><br/><label>Standard No.: </label>10.1371/journal.pmed.1003005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Viral--blood<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Immunization Schedule<br/>Immunoglobulin A--blood<br/>Infant<br/>Male<br/>Poliovirus Vaccine, Oral--administration & dosage<br/>Rotavirus--drug effects<br/>Rotavirus Infections--prevention & control<br/>Seroconversion--drug effects<br/>Treatment Outcome